Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Hock

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisBenjamin F Combes, Alicia Rosenau, Sheng-Fu Huang, et al.
Nature Communications|October 9, 2023
A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes modelsFabian Wirth, Fabrice D Heitz, Christine Seeger, et al.
Archives of Neurology|January 21, 2003
Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphismAndreas Papassotiropoulos, Johannes R Streffer, Magdalini Tsolaki, et al.
Nature Communications|May 22, 2019
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progressionFilip Liebsch, Luka Kulic, Charlotte Teunissen, et al.
Neuron|May 27, 2003
Antibodies against beta-amyloid slow cognitive decline in Alzheimer's diseaseChristoph Hock, Uwe Konietzko, Johannes R Streffer, et al.
The European Journal of Neuroscience|September 21, 2016
Hippocampal shape alterations are associated with regional Aβ load in cognitively normal elderly individualsClemens Schroeder, Min Tae M Park, Jürgen Germann, et al.
Neurobiology of Aging|February 24, 2015
Regional cerebral blood flow estimated by early PiB uptake is reduced in mild cognitive impairment and associated with age in an amyloid-dependent mannerAnton F Gietl, Geoffrey Warnock, Florian Riese, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's diseaseGiancarlo V De Ferrari, Andreas Papassotiropoulos, Travis Biechele, et al.
Neurobiology of Aging|January 10, 2018
Brain amyloid burden and cerebrovascular disease are synergistically associated with neurometabolism in cognitively unimpaired older adultsSimon J Schreiner, Thomas Kirchner, Atul Narkhede, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Point of view: Challenges in implementation of new immunotherapies for Alzheimer's diseaseSandar Aye, Gunilla Johansson, Christoph Hock, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisBenjamin F Combes, Alicia Rosenau, Sheng-Fu Huang, et al.
Nature Communications|October 9, 2023
A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes modelsFabian Wirth, Fabrice D Heitz, Christine Seeger, et al.
Archives of Neurology|January 21, 2003
Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphismAndreas Papassotiropoulos, Johannes R Streffer, Magdalini Tsolaki, et al.
Nature Communications|May 22, 2019
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progressionFilip Liebsch, Luka Kulic, Charlotte Teunissen, et al.
Neuron|May 27, 2003
Antibodies against beta-amyloid slow cognitive decline in Alzheimer's diseaseChristoph Hock, Uwe Konietzko, Johannes R Streffer, et al.
The European Journal of Neuroscience|September 21, 2016
Hippocampal shape alterations are associated with regional Aβ load in cognitively normal elderly individualsClemens Schroeder, Min Tae M Park, Jürgen Germann, et al.
Neurobiology of Aging|February 24, 2015
Regional cerebral blood flow estimated by early PiB uptake is reduced in mild cognitive impairment and associated with age in an amyloid-dependent mannerAnton F Gietl, Geoffrey Warnock, Florian Riese, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's diseaseGiancarlo V De Ferrari, Andreas Papassotiropoulos, Travis Biechele, et al.
Neurobiology of Aging|January 10, 2018
Brain amyloid burden and cerebrovascular disease are synergistically associated with neurometabolism in cognitively unimpaired older adultsSimon J Schreiner, Thomas Kirchner, Atul Narkhede, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Point of view: Challenges in implementation of new immunotherapies for Alzheimer's diseaseSandar Aye, Gunilla Johansson, Christoph Hock, et al.
Pageof 13